A Patient-Partnered, Pan-Canadian, Comparative Effectiveness Evaluation of an Acute Pediatric Mental Health and Addiction Care Bundle
Launched by UNIVERSITY OF CALGARY · May 20, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special care program designed to help children and teenagers who are facing mental health issues or substance use problems when they visit the emergency department. The goal is to see if this new care package can improve their well-being after 30 days compared to the usual care they would receive. The trial will take place at eight different sites across Canada and is currently recruiting participants aged 8 to 17 years who are experiencing specific mental health concerns, such as anxiety, depression, or behavioral issues.
To participate, children and youth need to have been assessed for one of the mentioned mental health concerns when they come to the emergency department. However, some individuals will not be eligible, such as those who have more serious mental health conditions or who have recently attempted self-harm. Participants in the trial can expect to receive either the new care program or the standard care and will be followed up with after a month to see how they are doing. This study is important because it aims to find better ways to support young people in crisis and improve their overall mental health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 8 to 17.99 years
- 2. Chief triage concern of at least one of the following (or comparable) mental health CEDIS triage categories:
- • 1. Anxiety/situational crisis and/or hyperventilation
- • 2. Bizarre/paranoid behaviour
- • 3. Concern for patient's welfare
- • 4. Depression/suicidal/deliberate self-harm
- • 5. Hallucinations/delusions
- • 6. Violent/homicidal behaviour
- • 7. Insomnia
- • 8. Pediatric disruptive behaviour
- Exclusion Criteria:
- • 1. Brought to the ED under provincial mental health legislation
- • 2. Exhibiting features of schizophrenia, schizotypal, delusional disorders, or psychosis (e.g., hallucinations/delusions complaint should be reviewed carefully for this exclusion criterion)
- • 3. Significant self-harm act (i.e., suicide attempt requiring medical clearance, excluding ideation or minor superficial wounds; e.g., laceration/puncture, overdose ingestion, etc.)
- • 4. Other co-morbid medical concerns requiring oversight and/or medical clearance from an emergency physician (e.g., confusion/disorientation, substance withdrawal, other medical complaints, etc.)
- • 5. Substance misuse/intoxication or altered level of consciousness
- • 6. Exhibiting a behavioural syndrome associated with physiologic disturbances (e.g., anorexia)
- Children/youth will also be excluded based on language barriers:
- • 7. Language barrier (i.e., patient and parent/legal guardian must be fluent in either English or French)
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
London, Ontario, Canada
Hamilton, Ontario, Canada
Toronto, Ontario, Canada
Montréal, Quebec, Canada
Saskatoon, Saskatchewan, Canada
Saint John's, Newfoundland And Labrador, Canada
Winnipeg, Manitoba, Canada
Patients applied
Trial Officials
Stephen Freedman, MDCM, MSc
Principal Investigator
University of Calgary
Amanda Newton, PhD
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials